Engineered Extracellular Vesicles in Chronic Kidney Diseases: A Comprehensive Review

Overview

Journal Int J Nanomedicine

Publisher Dove Medical Press

Specialty Biotechnology

Date 2024 Mar 12

PMID 38469058

Authors

Kaming Xue

Bobin Mi

Affiliations

Soon will be listed here.

Abstract

Chronic kidney diseases (CKD) present a formidable global health challenge, characterized by a deficiency of effective treatment options. Extracellular vesicles (EVs), recognized as multifunctional drug delivery systems in biomedicine, have gained accumulative interest. Specifically, engineered EVs have emerged as a promising therapeutic approach for targeted drug delivery, potentially addressing the complexities of CKD management. In this review, we systematically dissect EVs, elucidating their classification, biogenesis, composition, and cargo molecules. Furthermore, we explore techniques for EV engineering and strategies for their precise renal delivery, focusing on cargo loading and transportation, providing a comprehensive perspective. Moreover, this review also discusses and summarizes the diverse therapeutic applications of engineered EVs in CKD, emphasizing their anti-inflammatory, immunomodulatory, renoprotective, and tissue-regenerating effects. It critically evaluates the challenges and limitations in translating EV therapies from laboratory settings to clinical applications, while outlining future prospects and emerging trends.

References

Jeppesen D, Zhang Q, Franklin J, Coffey R . Extracellular vesicles and nanoparticles: emerging complexities. Trends Cell Biol. 2023; 33(8):667-681. PMC: 10363204. DOI: 10.1016/j.tcb.2023.01.002. View

Zhou M, Li Y, Tang Y, Hao X, Xu W, Xiang D . Apoptotic bodies for advanced drug delivery and therapy. J Control Release. 2022; 351:394-406. DOI: 10.1016/j.jconrel.2022.09.045. View

El Fekih R, Hurley J, Tadigotla V, Alghamdi A, Srivastava A, Coticchia C . Discovery and Validation of a Urinary Exosome mRNA Signature for the Diagnosis of Human Kidney Transplant Rejection. J Am Soc Nephrol. 2021; 32(4):994-1004. PMC: 8017553. DOI: 10.1681/ASN.2020060850. View

Yang J, Zhang X, Wang G, Ma S, Yu Y, Liao C . ApoSEVs-Mediated Modulation of Versatile Target Cells Promotes Diabetic Wound Healing: Unveiling a Promising Strategy. Int J Nanomedicine. 2023; 18:6955-6977. PMC: 10676647. DOI: 10.2147/IJN.S436350. View

Hu Z, Chen G, Zhao Y, Gao H, Li L, Yin Y . Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. Mol Cancer. 2023; 22(1):55. PMC: 10024440. DOI: 10.1186/s12943-023-01759-1. View

Erdbrugger U, Blijdorp C, Bijnsdorp I, Borras F, Burger D, Bussolati B . Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesicles. J Extracell Vesicles. 2021; 10(7):e12093. PMC: 8138533. DOI: 10.1002/jev2.12093. View

Tao Y, Wei X, Yue Y, Wang J, Li J, Shen L . Extracellular vesicle-derived AEBP1 mRNA as a novel candidate biomarker for diabetic kidney disease. J Transl Med. 2021; 19(1):326. PMC: 8325821. DOI: 10.1186/s12967-021-03000-3. View

Martin P, Awan A, Berenguer M, Bruchfeld A, Fabrizi F, Goldberg D . Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney Int. 2022; 102(6):1228-1237. DOI: 10.1016/j.kint.2022.07.012. View

Whitley J, Cai H . Engineering extracellular vesicles to deliver CRISPR ribonucleoprotein for gene editing. J Extracell Vesicles. 2023; 12(9):e12343. PMC: 10507228. DOI: 10.1002/jev2.12343. View

10.

Yu Y, Chen M, Guo Q, Shen L, Liu X, Pan J . Human umbilical cord mesenchymal stem cell exosome-derived miR-874-3p targeting RIPK1/PGAM5 attenuates kidney tubular epithelial cell damage. Cell Mol Biol Lett. 2023; 28(1):12. PMC: 9903493. DOI: 10.1186/s11658-023-00425-0. View

11.

Lv L, Feng Y, Wu M, Wang B, Li Z, Zhong X . Exosomal miRNA-19b-3p of tubular epithelial cells promotes M1 macrophage activation in kidney injury. Cell Death Differ. 2019; 27(1):210-226. PMC: 7206053. DOI: 10.1038/s41418-019-0349-y. View

12.

Chen J, Tan Q, Yang Z, Jin Y . Engineered extracellular vesicles: potentials in cancer combination therapy. J Nanobiotechnology. 2022; 20(1):132. PMC: 8922858. DOI: 10.1186/s12951-022-01330-y. View

13.

Chen S, Zhang M, Li J, Huang J, Zhou S, Hou X . β-catenin-controlled tubular cell-derived exosomes play a key role in fibroblast activation via the OPN-CD44 axis. J Extracell Vesicles. 2022; 11(3):e12203. PMC: 8936047. DOI: 10.1002/jev2.12203. View

14.

Han L, Wang S, Li J, Zhao L, Zhou H . Urinary exosomes from patients with diabetic kidney disease induced podocyte apoptosis via microRNA-145-5p/Srgap2 and the RhoA/ROCK pathway. Exp Mol Pathol. 2023; 134:104877. DOI: 10.1016/j.yexmp.2023.104877. View

15.

Jalal D, Sanford B, Renner B, Ten Eyck P, Laskowski J, Cooper J . Detection of pro angiogenic and inflammatory biomarkers in patients with CKD. Sci Rep. 2021; 11(1):8786. PMC: 8062467. DOI: 10.1038/s41598-021-87710-0. View

16.

Ceccotti E, Saccu G, Herrera Sanchez M, Bruno S . Naïve or Engineered Extracellular Vesicles from Different Cell Sources: Therapeutic Tools for Kidney Diseases. Pharmaceutics. 2023; 15(6). PMC: 10303377. DOI: 10.3390/pharmaceutics15061715. View

17.

Zhou S, Cheing G, Cheung A . Role of exosomes and exosomal microRNA in muscle-Kidney crosstalk in chronic kidney disease. Front Cell Dev Biol. 2022; 10:951837. PMC: 9490178. DOI: 10.3389/fcell.2022.951837. View

18.

Haney N, Kim C, Kuczler M, Lee C, Lombardo K, Bivalacqua T . Novel urinary tract obstruction marker discovery by multi-marker profiling of urinary extracellular vesicles derived from a rat UTO model. Am J Clin Exp Urol. 2023; 11(2):136-145. PMC: 10165232. View

19.

Ji C, Zhang J, Shi L, Shi H, Xu W, Jin J . Engineered extracellular vesicle-encapsulated CHIP as novel nanotherapeutics for treatment of renal fibrosis. NPJ Regen Med. 2024; 9(1):3. PMC: 10787844. DOI: 10.1038/s41536-024-00348-0. View

20.

Yang B, Lin Y, Huang Y, Zhu N, Shen Y . Extracellular vesicles modulate key signalling pathways in refractory wound healing. Burns Trauma. 2023; 11:tkad039. PMC: 10654481. DOI: 10.1093/burnst/tkad039. View